5 results  1 of 1 

1 Involvement of the cannabinoid system in chronic inflammatory intestinal diseases: opportunities for new therapies
Priscila A. Lima, Bárbara B. Berg, Marina Gomes Miranda e Castor
Intest Res.2022;20(4):392-417.   Published online 2022 May 31     DOI: http://dx.doi.org/10.5217/ir.2021.00160
      
2 SR144528 as Inverse Agonist of CB2 Cannabinoid Receptor
Man Hee Rhee, Sang Keun Kim
J Vet Sci.2002;3(3):179-184.   Published online 2019 February 13     DOI: http://dx.doi.org/10.4142/jvs.2002.3.3.179
      
3 Functional Role of Serine Residues of Transmembrane Dopamin VII in Signal Transduction of CB2 Cannabinoid Receptor
Man Hee Rhee
J Vet Sci.2002;3(3):185-191.   Published online 2019 February 13     DOI: http://dx.doi.org/10.4142/jvs.2002.3.3.185
      
4 Pain medication and long QT syndrome
Christoph Klivinyi, Helmar Bornemann-Cimenti
Korean J Pain.2018;31(1):3-9.   Published online 2018 January 2     DOI: http://dx.doi.org/10.3344/kjp.2018.31.1.3
      
5 Drug therapy of overactive bladder - What is coming next?
Karl-Erik Andersson
Korean J Urol.2015;56(10):673-679.   Published online 2015 October 2     DOI: http://dx.doi.org/10.4111/kju.2015.56.10.673
      

 1 of 1